Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
A sneak peak of the 2015 report on the market of type 2 diabetes mellitus diagnosis and treatment in China.

Annals of translational medicine

Li X, Zhan Y, Wang Q, Xu Y, Liu Y, Wang X, Ren Y.
PMID: 26207248
Ann Transl Med. 2015 Jun;3(9):120. doi: 10.3978/j.issn.2305-5839.2015.06.09.

To understand the status quo of the diagnosis and treatment of type 2 diabetes mellitus (T2DM) in China. A total of 1,759 respondents from 31 provinces, municipalities, and autonomous regions participated this online questionnaire-based survey from November to December...

Cite
Li X, Zhan Y, Wang Q, et al. A sneak peak of the 2015 report on the market of type 2 diabetes mellitus diagnosis and treatment in China. Ann Transl Med. 2015;3(9):120doi: 10.3978/j.issn.2305-5839.2015.06.09.
Li, X., Zhan, Y., Wang, Q., Xu, Y., Liu, Y., Wang, X., & Ren, Y. (2015). A sneak peak of the 2015 report on the market of type 2 diabetes mellitus diagnosis and treatment in China. Annals of translational medicine, 3(9), 120. https://doi.org/10.3978/j.issn.2305-5839.2015.06.09
Li, Xingwei, et al. "A sneak peak of the 2015 report on the market of type 2 diabetes mellitus diagnosis and treatment in China." Annals of translational medicine vol. 3,9 (2015): 120. doi: https://doi.org/10.3978/j.issn.2305-5839.2015.06.09
Li X, Zhan Y, Wang Q, Xu Y, Liu Y, Wang X, Ren Y. A sneak peak of the 2015 report on the market of type 2 diabetes mellitus diagnosis and treatment in China. Ann Transl Med. 2015 Jun;3(9):120. doi: 10.3978/j.issn.2305-5839.2015.06.09. PMID: 26207248; PMCID: PMC4481362.
Copy Download .nbib Format: NLM
Comparative efficacy and safety of long-acting insulin analogs in patients with type 2 diabetes failing on oral therapy: Systemic review and meta-analyses.

Journal of diabetes investigation

Bi Y, Li X, Yang D, Hao Y, Liang H, Zhu D, Weng J.
PMID: 24843578
J Diabetes Investig. 2012 Jun 06;3(3):283-93. doi: 10.1111/j.2040-1124.2011.00187.x.

UNLABELLED: Aims/Introduction:  Although long-acting insulin analogs are recommended in type 2 diabetics failing on oral agents, their efficacy is uncertain. Here we compared the efficacy and safety of regimens based on long-acting insulin analogs with other preparations in insulin-naïve...

Cite
Bi Y, Li X, Yang D, et al. Comparative efficacy and safety of long-acting insulin analogs in patients with type 2 diabetes failing on oral therapy: Systemic review and meta-analyses. J Diabetes Investig. 2012;3(3):283-93doi: 10.1111/j.2040-1124.2011.00187.x.
Bi, Y., Li, X., Yang, D., Hao, Y., Liang, H., Zhu, D., & Weng, J. (2012). Comparative efficacy and safety of long-acting insulin analogs in patients with type 2 diabetes failing on oral therapy: Systemic review and meta-analyses. Journal of diabetes investigation, 3(3), 283-93. https://doi.org/10.1111/j.2040-1124.2011.00187.x
Bi, Yan, et al. "Comparative efficacy and safety of long-acting insulin analogs in patients with type 2 diabetes failing on oral therapy: Systemic review and meta-analyses." Journal of diabetes investigation vol. 3,3 (2012): 283-93. doi: https://doi.org/10.1111/j.2040-1124.2011.00187.x
Bi Y, Li X, Yang D, Hao Y, Liang H, Zhu D, Weng J. Comparative efficacy and safety of long-acting insulin analogs in patients with type 2 diabetes failing on oral therapy: Systemic review and meta-analyses. J Diabetes Investig. 2012 Jun 06;3(3):283-93. doi: 10.1111/j.2040-1124.2011.00187.x. PMID: 24843578; PMCID: PMC4014951.
Copy Download .nbib Format: NLM
Effectiveness and safety of insulin glargine .

Therapeutic advances in endocrinology and metabolism

Silva TBC, Almeida PHRF, Araújo VE, Acurcio FA, Guerra Júnior AA, Godman B, Alvares J.
PMID: 30181850
Ther Adv Endocrinol Metab. 2018 Jun 22;9(8):241-254. doi: 10.1177/2042018818781414. eCollection 2018.

BACKGROUND: Diabetes mellitus type 1 (DM1) is an autoimmune disease characterized by metabolic destruction of pancreatic cells responsible for insulin production, with treatment based on replacing insulin. Long-acting insulin analogs are indicated for patients with DM1 who exhibit important...

Cite
Silva TBC, Almeida PHRF, Araújo VE, et al. Effectiveness and safety of insulin glargine . Ther Adv Endocrinol Metab. 2018;9(8):241-254doi: 10.1177/2042018818781414.
Silva, T. B. C., Almeida, P. H. R. F., Araújo, V. E., Acurcio, F. A., Guerra Júnior, A. A., Godman, B., & Alvares, J. (2018). Effectiveness and safety of insulin glargine . Therapeutic advances in endocrinology and metabolism, 9(8), 241-254. https://doi.org/10.1177/2042018818781414
Silva, Thales B C, et al. "Effectiveness and safety of insulin glargine ." Therapeutic advances in endocrinology and metabolism vol. 9,8 (2018): 241-254. doi: https://doi.org/10.1177/2042018818781414
Silva TBC, Almeida PHRF, Araújo VE, Acurcio FA, Guerra Júnior AA, Godman B, Alvares J. Effectiveness and safety of insulin glargine . Ther Adv Endocrinol Metab. 2018 Jun 22;9(8):241-254. doi: 10.1177/2042018818781414. eCollection 2018. PMID: 30181850; PMCID: PMC6116758.
Copy Download .nbib Format: NLM
Comparison of Prevailing Insulin Regimens at Different Time Periods in Hospitalized Patients: A Real-World Experience from a Tertiary Hospital.

Diabetes & metabolism journal

Moon SJ, Choe HJ, Kwak SH, Jung HS, Park KS, Cho YM.
PMID: 34666425
Diabetes Metab J. 2021 Oct 20; doi: 10.4093/dmj.2021.0065. Epub 2021 Oct 20.

BACKGROUND: Prevailing insulin regimens for glycemic control in hospitalized patients have changed over time. We aimed to determine whether the current basal-bolus insulin (BBI) regimen is superior to the previous insulin regimen, mainly comprising split-mixed insulin therapy.METHODS: This was...

Cite
Moon SJ, Choe HJ, Kwak SH, et al. Comparison of Prevailing Insulin Regimens at Different Time Periods in Hospitalized Patients: A Real-World Experience from a Tertiary Hospital. Diabetes Metab J. 2021;doi: 10.4093/dmj.2021.0065.
Moon, S. J., Choe, H. J., Kwak, S. H., Jung, H. S., Park, K. S., & Cho, Y. M. (2021). Comparison of Prevailing Insulin Regimens at Different Time Periods in Hospitalized Patients: A Real-World Experience from a Tertiary Hospital. Diabetes & metabolism journal, . https://doi.org/10.4093/dmj.2021.0065
Moon, Sun Joon, et al. "Comparison of Prevailing Insulin Regimens at Different Time Periods in Hospitalized Patients: A Real-World Experience from a Tertiary Hospital." Diabetes & metabolism journal vol. (2021). doi: https://doi.org/10.4093/dmj.2021.0065
Moon SJ, Choe HJ, Kwak SH, Jung HS, Park KS, Cho YM. Comparison of Prevailing Insulin Regimens at Different Time Periods in Hospitalized Patients: A Real-World Experience from a Tertiary Hospital. Diabetes Metab J. 2021 Oct 20; doi: 10.4093/dmj.2021.0065. Epub 2021 Oct 20. PMID: 34666425.
Copy Download .nbib Format: NLM
Switching to multiple daily insulin injections in children and adolescents with type 1 diabetes: revisiting benefits from oman.

Oman medical journal

Sharef SW, Ullah I, Al-Shidhani A, Al-Farsi T, Al-Yaarubi S.
PMID: 25960831
Oman Med J. 2015 Mar;30(2):83-9. doi: 10.5001/omj.2015.19.

OBJECTIVES: Optimal glycemic control is an important goal in the management of type 1 diabetes mellitus (T1DM). Although the use of multiple daily injections (MDI) is a common regimen worldwide, its use is not yet universal in many countries....

Cite
Sharef SW, Ullah I, Al-Shidhani A, et al. Switching to multiple daily insulin injections in children and adolescents with type 1 diabetes: revisiting benefits from oman. Oman Med J. 2015;30(2):83-9doi: 10.5001/omj.2015.19.
Sharef, S. W., Ullah, I., Al-Shidhani, A., Al-Farsi, T., & Al-Yaarubi, S. (2015). Switching to multiple daily insulin injections in children and adolescents with type 1 diabetes: revisiting benefits from oman. Oman medical journal, 30(2), 83-9. https://doi.org/10.5001/omj.2015.19
Sharef, Sharef Waadallah, et al. "Switching to multiple daily insulin injections in children and adolescents with type 1 diabetes: revisiting benefits from oman." Oman medical journal vol. 30,2 (2015): 83-9. doi: https://doi.org/10.5001/omj.2015.19
Sharef SW, Ullah I, Al-Shidhani A, Al-Farsi T, Al-Yaarubi S. Switching to multiple daily insulin injections in children and adolescents with type 1 diabetes: revisiting benefits from oman. Oman Med J. 2015 Mar;30(2):83-9. doi: 10.5001/omj.2015.19. PMID: 25960831; PMCID: PMC4412454.
Copy Download .nbib Format: NLM
The Effect of Type and Daily Doses of Insulin to Treatment Success in Type 2 Diabetes Patients who are Receiving Basal-bolus Insulin Therapy.

Sisli Etfal Hastanesi tip bulteni

Ozturkmen YA, Avci S, Calim A, Cetin EG, Demir N, Mazi EE, Borlu F, Altuntas Y.
PMID: 33364880
Sisli Etfal Hastan Tip Bul. 2020 Dec 11;54(4):416-423. doi: 10.14744/SEMB.2018.58234. eCollection 2020.

OBJECTIVES: The present study aims to compare different types of insulin concerning treatment success and insulin dose requirement in type 2 diabetes patients who were receiving basal-bolus insulin therapy and to evaluate the causes of treatment failure despite high...

Cite
Ozturkmen YA, Avci S, Calim A, et al. The Effect of Type and Daily Doses of Insulin to Treatment Success in Type 2 Diabetes Patients who are Receiving Basal-bolus Insulin Therapy. Sisli Etfal Hastan Tip Bul. 2020;54(4):416-423doi: 10.14744/SEMB.2018.58234.
Ozturkmen, Y. A., Avci, S., Calim, A., Cetin, E. G., Demir, N., Mazi, E. E., Borlu, F., & Altuntas, Y. (2020). The Effect of Type and Daily Doses of Insulin to Treatment Success in Type 2 Diabetes Patients who are Receiving Basal-bolus Insulin Therapy. Sisli Etfal Hastanesi tip bulteni, 54(4), 416-423. https://doi.org/10.14744/SEMB.2018.58234
Ozturkmen, Yuksel Asli, et al. "The Effect of Type and Daily Doses of Insulin to Treatment Success in Type 2 Diabetes Patients who are Receiving Basal-bolus Insulin Therapy." Sisli Etfal Hastanesi tip bulteni vol. 54,4 (2020): 416-423. doi: https://doi.org/10.14744/SEMB.2018.58234
Ozturkmen YA, Avci S, Calim A, Cetin EG, Demir N, Mazi EE, Borlu F, Altuntas Y. The Effect of Type and Daily Doses of Insulin to Treatment Success in Type 2 Diabetes Patients who are Receiving Basal-bolus Insulin Therapy. Sisli Etfal Hastan Tip Bul. 2020 Dec 11;54(4):416-423. doi: 10.14744/SEMB.2018.58234. eCollection 2020. PMID: 33364880; PMCID: PMC7751243.
Copy Download .nbib Format: NLM
Epidemiology of hypoglycaemic episodes leading to hospitalisations in Denmark in 1998-2018.

Diabetologia

Jensen MH, Hejlesen O, Vestergaard P.
PMID: 34245315
Diabetologia. 2021 Oct;64(10):2193-2203. doi: 10.1007/s00125-021-05507-2. Epub 2021 Jul 10.

AIMS/HYPOTHESIS: We aimed to investigate the nationwide trends in incidence and associated risk factors, with focus on blood glucose-lowering medication, for the first hypoglycaemic episode leading to hospitalisation in Denmark among people with type 1 and 2 diabetes mellitus.METHODS:...

Cite
Jensen MH, Hejlesen O, Vestergaard P. Epidemiology of hypoglycaemic episodes leading to hospitalisations in Denmark in 1998-2018. Diabetologia. 2021;64(10):2193-2203doi: 10.1007/s00125-021-05507-2.
Jensen, M. H., Hejlesen, O., & Vestergaard, P. (2021). Epidemiology of hypoglycaemic episodes leading to hospitalisations in Denmark in 1998-2018. Diabetologia, 64(10), 2193-2203. https://doi.org/10.1007/s00125-021-05507-2
Jensen, Morten H, et al. "Epidemiology of hypoglycaemic episodes leading to hospitalisations in Denmark in 1998-2018." Diabetologia vol. 64,10 (2021): 2193-2203. doi: https://doi.org/10.1007/s00125-021-05507-2
Jensen MH, Hejlesen O, Vestergaard P. Epidemiology of hypoglycaemic episodes leading to hospitalisations in Denmark in 1998-2018. Diabetologia. 2021 Oct;64(10):2193-2203. doi: 10.1007/s00125-021-05507-2. Epub 2021 Jul 10. PMID: 34245315.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries